- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Adaptive Biotechnologies Corp (ADPT)
7.990
-0.140(-1.72%)
Closed
After Hours
7.9900.000(0.00%)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
7.875
8.260
52 wk Range
2.280
8.330
ADPT Income Statement
Explore the detailed Adaptive Biotechnologies Corp income statement, offering a comprehensive view of the company’s financial performance. Review essential metrics such as revenue, gross profit, operating income, and net income over selected periods. This page provides a clear breakdown of profitability and operational efficiency, helping you evaluate Adaptive Biotechnologies Corp's growth trends and overall financial health.
Advanced Income Statement
| Period Ending: | 2017 31/12 | 2018 31/12 | 2019 31/12 | 2020 31/12 | 2021 31/12 | 2022 31/12 | 2023 31/12 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenues | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | 185.31 | 170.28 | |||||||||
Total Revenues Growth | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | +20.06% | -8.11% | |||||||||
Cost Of Revenues | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | 199.67 | 197.67 | |||||||||
Gross Profit | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | -14.36 | -27.39 | |||||||||
Gross Profit Growth | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | +61.51% | -90.81% | |||||||||
Gross Profit Margin % | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | -7.75% | -16.09% | |||||||||
Other Operating Expenses, Total | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | 185.83 | 174.21 | |||||||||
| ||||||||||||||||
Operating Income | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | -200.19 | -201.61 | |||||||||
Operating Income Growth | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | +4.2% | -0.71% | |||||||||
EBIT Margin % | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | -108.03% | -118.4% | |||||||||
Net Interest Expenses | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | 0.56 | -7.45 | |||||||||
Net Interest Expenses Growth | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | -93.72% | -1,433.27% | |||||||||
Interest Expense, Total | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | -4.24 | -13.8 | |||||||||
Interest And Investment Income | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | 4.8 | 6.35 | |||||||||
Other Non Operating Expenses, Total | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | - | - | |||||||||
EBT, Excl. Unusual Items | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | -199.63 | -209.06 | |||||||||
Gain (Loss) On Sale Of Assets | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | - | - | |||||||||
Other Unusual Items, Total | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | - | -25.43 | |||||||||
EBT, Incl. Unusual Items | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | -200.37 | -225.3 | |||||||||
EBT, Incl. Unusual Items Growth | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | +3.34% | -12.45% | |||||||||
EBT, Incl. Unusual Items Margin | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | -108.13% | -132.32% | |||||||||
Income Tax Expense | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | - | - | |||||||||
Net Income to Company | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | -200.37 | -225.3 | |||||||||
Minority Interest | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | 0.18 | 0.05 | |||||||||
Net Income | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | -200.19 | -225.25 | |||||||||
Net Income Growth | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | +3.42% | -12.52% | |||||||||
Net Income Margin % | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | -108.03% | -132.29% | |||||||||
Preferred Dividend and Other Adjustments | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | - | - | |||||||||
Net Income to Common Excl. Extra Items | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | -200.19 | -225.25 | |||||||||
Basic EPS - Continuing Operations | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | -1.4 | -1.56 | |||||||||
Basic EPS - Continuing Operations Growth | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | +4.88% | -11.06% | |||||||||
Diluted EPS - Continuing Operations | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | -1.4 | -1.56 | |||||||||
Diluted EPS - Continuing Operations Growth | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | +4.88% | -11.06% | |||||||||
Basic Weighted Average Shares Outstanding | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | 142.52 | 144.38 | |||||||||
Diluted Weighted Average Shares Outstanding | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | 142.52 | 144.38 | |||||||||
Dividend Per Share | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | - | - | |||||||||
Dividend Per Share Growth | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | - | - | |||||||||
EBITDA | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | -179.27 | -179.38 | |||||||||
EBITDA Growth | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | +8.07% | -0.06% | |||||||||
EBITDA Margin % | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | -96.74% | -105.34% | |||||||||
EBIT | aa.aa | aa.aa | aa.aa | |||||||||||||